Stonepine Capital Management, LLC Quant / Systematic

Name: Stonepine Capital Management, LLC Q3 2020 13F Filing | 13F Explorer
Creator: Stonepine Capital Management, LLC
Published: 2020-11-13

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 13, 2020

Total Value: $96.13M (100.0% shares, 0.0% debt)

Holdings (17)

LGND LIGAND PHARMACEUTICALS 31.9%

Value $30.64M Shares 321,500 Share Price $95.32 * Est. Cost/Share $64.91 Unrealized @ Report Date +5.1%

— IVERIC BIO INC 13.9%

Value $13.32M Shares 2,362,240 Share Price $5.64 Est. Cost/Share $1.52 Unrealized @ Report Date —

— AMRYT PHARMA LTD - SPNR ADR 9.8%

Value $9.458M Shares 765,236 Share Price $12.36 Est. Cost/Share $12.36 Unrealized @ Report Date —

— CTI BIOPHARMA CORP 8.4%

Value $8.102M Shares 3,768,597 Share Price $2.15 Est. Cost/Share $2.16 Unrealized @ Report Date —

— CATALYST BIOSCIENCES INC 6.3%

Value $6.069M Shares 1,411,412 Share Price $4.30 Est. Cost/Share $4.61 Unrealized @ Report Date —

DMAC DIAMEDICA THERAPEUTICS INC 5.1%

Value $4.861M Shares 1,146,470 Share Price $4.24 * Est. Cost/Share $4.62 Unrealized @ Report Date +14.6%

— STRONGBRIDGE BIOPHARMA PLC 4.2%

Value $4.042M Shares 1,924,956 Share Price $2.10 Est. Cost/Share $2.10 Unrealized @ Report Date —

— ANTARES PHARMA INC 3.4%

Value $3.255M Shares 1,205,501 Share Price $2.70 Est. Cost/Share $2.70 Unrealized @ Report Date —

XOMA XOMA CORP 2.9%

Value $2.83M Shares 150,213 Share Price $18.84 Est. Cost/Share $14.24 Unrealized @ Report Date +31.6%

— ADAMAS PHARMACEUTICALS INC 2.8%

Value $2.709M Shares 657,467 Share Price $4.12 Est. Cost/Share $4.81 Unrealized @ Report Date —

— APOLLO ENDOSURGERY INC 2.5%

Value $2.409M Shares 1,425,435 Share Price $1.69 Est. Cost/Share $4.35 Unrealized @ Report Date —

— NEOS THERAPEUTICS INC 2.4%

Value $2.325M Shares 4,384,199 Share Price $0.53 Est. Cost/Share $1.80 Unrealized @ Report Date —

CPIX CUMBERLAND PHARMACEUTICALS 2.0%

Value $1.892M Shares 589,497 Share Price $3.21 * Est. Cost/Share $5.80 Unrealized @ Report Date -43.3%

— CHIASMA INC 1.6%

Value $1.505M Shares 350,000 Share Price $4.30 Est. Cost/Share $4.30 Unrealized @ Report Date —

— AFFIMED NV 1.3%

Value $1.212M Shares 357,666 Share Price $3.39 Est. Cost/Share $3.39 Unrealized @ Report Date —

IDXG INTERPACE BIOSCIENCES INC 0.9%

Value $880K Shares 284,730 Share Price $3.09 Est. Cost/Share $3.09 Unrealized @ Report Date —

— PROGENITY INC 0.6%

Value $614K Shares 68,062 Share Price $9.02 Est. Cost/Share $9.00 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
LGND	LIGAND PHARMACEUTICALS	321,500	$30.64M	31.9%	$95.32 *	$64.91	+5.1%	COM NEW	53220K504
—	IVERIC BIO INC	2,362,240	$13.32M	13.9%	$5.64	$1.52	—	COM	46583P102
—	AMRYT PHARMA LTD - SPNR ADR	765,236	$9.458M	9.8%	$12.36	$12.36	—	SPONSORED ADS	03217L106
—	CTI BIOPHARMA CORP	3,768,597	$8.102M	8.4%	$2.15	$2.16	—	COM	12648L601
—	CATALYST BIOSCIENCES INC	1,411,412	$6.069M	6.3%	$4.30	$4.61	—	COM NEW	14888D208
DMAC	DIAMEDICA THERAPEUTICS INC	1,146,470	$4.861M	5.1%	$4.24 *	$4.62	+14.6%	COM NEW	25253X207
—	STRONGBRIDGE BIOPHARMA PLC	1,924,956	$4.042M	4.2%	$2.10	$2.10	—	SHS USD	G85347105
—	ANTARES PHARMA INC	1,205,501	$3.255M	3.4%	$2.70	$2.70	—	COM	036642106
XOMA	XOMA CORP	150,213	$2.83M	2.9%	$18.84	$14.24	+31.6%	COM NEW	98419J206
—	ADAMAS PHARMACEUTICALS INC	657,467	$2.709M	2.8%	$4.12	$4.81	—	COM	00548A106
—	APOLLO ENDOSURGERY INC	1,425,435	$2.409M	2.5%	$1.69	$4.35	—	COM	03767D108
—	NEOS THERAPEUTICS INC	4,384,199	$2.325M	2.4%	$0.53	$1.80	—	COM	64052L106
CPIX	CUMBERLAND PHARMACEUTICALS	589,497	$1.892M	2.0%	$3.21 *	$5.80	-43.3%	COM	230770109
—	CHIASMA INC	350,000	$1.505M	1.6%	$4.30	$4.30	—	COM	16706W102
—	AFFIMED NV	357,666	$1.212M	1.3%	$3.39	$3.39	—	COM	N01045108
IDXG	INTERPACE BIOSCIENCES INC	284,730	$880K	0.9%	$3.09	$3.09	—	COM	46062X303
—	PROGENITY INC	68,062	$614K	0.6%	$9.02	$9.00	—	COM	74319F107